Quality control and drug-drug interactions between commercially available Metoprolol and Glimepiride tablets
DOI:
https://doi.org/10.1590/s2175-97902022e20349Palavras-chave:
Quality control test of tablets, In vitro drug release study, Drug drug interaction study, Metoprolol Tartrate and GlimepirideResumo
Quality is paramount and needs to be maintained throughout the shelf life of pharmaceuticals. The current study aimed to evaluate the quality, potency, and drug-drug interaction in an in vivo animal model by using two drugs, namely, metoprolol and glimepiride. Tablets were selected for their physical characteristics, such as shape, size, and color. Quality control tests, such as weight variation, hardness, friability, and disintegration tests, and invitro drug release studies were performed as per USP. Drug-drug interaction and in vivo studies were carried out according to the standard protocol of the animal ethics committee. Quality control tests of both the tablets were within the specified range. The cumulative release percentages of the drugs were 81.12% and 85.36% for Metoprolol Tartrate and Glimepiride, respectively, in a physiological buffer solution within 1 h. The combination of metoprolol and Glimepiride also significantly decreased the blood glucose level in diabetic animals. However, the blood glucose level increased in the group receiving metoprolol only, but the difference was not significant. The result suggested that the formulations are safe. However, the chronic use of this combination requires frequent monitoring of blood glucose level to improve its efficacy and for the patient’s safety.
Downloads
Referências
Abrantes CG, Duarte D, Reis CP. An overview of pharmaceutical excipients: safe or not safe? J Pharm Sci. 2016;105(7):2019-26.
Alsante KM, Ando A, Brown R, Ensing J, Hatajik TD, Kong W, Tsuda Y. The role of degradant profiling in active pharmaceutical ingredients and drug products. Adv Drug Deliv Rev. 2007;59(1):29-37.
Altinöz S, Tekeli D. Analysis of glimepiride by using derivative UV spectrophotometric method. J Pharm Biomed. 2001;24(3):507-15.
Amarji B, Kulkarni A, Deb PK, Maheshwari R, Tekade RK. Package Development of Pharmaceutical Products: Aspects of Packaging Materials Used for Pharmaceutical Products. In Dosage Form Design Parameters. 1st edition. Academic Press. 2018; 521-552.
Bajaj S, Singla D, Sakhuja N. Stability testing of pharmaceutical products. J App Pharm Sci. 2012;2(3):129- 138.
Bandari S, Mittapalli RK, Gannu R. Orodispersible tablets: An overview. Asian J Pharm. 2014;2(1).
Bharate SS, Bharate SB, Bajaj AN. Interactions and incompatibilities of pharmaceutical excipients with active pharmaceutical ingredients: a comprehensive review. J Excip Food Chem. 2016;1(3):1131.
Bhuyian MH, Rasyid DH, Mohsin M, Tahera KT. An overview: stability study of pharmaceutical product and shelf life prediction. EJBPS. 2015;2(6):30-40.
Bodea M, Tomuţă I, Leucuţa SE. Film coating preparation of metoprolol tartrate mini-tablets and in vitro drug release studies. Clujul Med. 2010;83(3):457-63.
Blanco M, Alcalá M, González JM, Torras E. A process analytical technology approach based on near infrared spectroscopy: tablet hardness, content uniformity, and dissolution test measurements of intact tablets. J Pharm Sci . 2006;95(10):2137-44.
Blessy MR, Patel RD, Prajapati PN, Agrawal YK. Development of forced degradation and stability indicating studies of drugs. J Pharm Anal. 2014;4(3):159-65.
Cefalu WT. Animal models of type 2 diabetes: clinical presentation and pathophysiological relevance to the human condition. ILARJ. 2006;47(3):186-98.
Cunningham VL, Binks SP, Olson MJ. Human health risk assessment from the presence of human pharmaceuticals in the aquatic environment. Regul Toxicol Pharmacol. 2009;53(1):39-45.
De Boer IH, Bangalore S, Benetos A, Davis AM, Michos ED, Muntner P, et al.Diabetes and hypertension: a position statement by the American Diabetes Association. Diabetes Care. 2017;40(9):1273-84.
de Oliveira Melo SR, Homem-de-Mello M, Silveira D, Simeoni LA. Advice on degradation products in pharmaceuticals: a toxicological evaluation. PDA J Pharm Sci Technol. 2014;68(3):221-38.
de Carvalho Mendes T, Simon A, Menezes JC, Pinto EC, Cabral LM, de Sousa VP. Development of USP Apparatus 3 Dissolution Method with IVIVC for extended release tablets of metformin hydrochloride and development of a generic formulation. Chem Pharm Bull. 2019;67(1):23-31.
Dixit RP, Puthli SP. Oral strip technology: overview and future potential. J Control Release. 2009;139(2):94-107.
Fathima N, Mamatha T, Qureshi HK, Anitha N, Rao JV. Drug-excipient interaction and its importance in dosage form development. J Appl Pharm Sci. 2011;1(06):66-71.
Geyer AR, Sousa VD, Silveira D. Quality of medicines: Deficiencies found by Brazilian Health Regulatory Agency (ANVISA) on good manufacturing practices international inspections. PLoS One. 2018;13(8):1-17.
Gohel MC, Patel TP, Bariya SH. Studies in Preparation and Evaluation of pH-Independent Sustained-Release Matrix Tablets of Verapamil HCl Using Directly Compressible Eudragits. Pharm Dev Technol. 2003;8(4):323-33.
Groop L, Tötterman KJ, Harno K, Gordin A. Influence of Beta-Blocking Drugs on Glucose Metabolism in Hypertensive, Non-Diabetic Patients. Acta Med Scand. 1983;213(1):9-14.
Gupta D, Dubey PK. Formulation and evaluation of Antiurolithiatic herbal tablet. J Drug Deliv Ther. 2019;9(4- s):908-13.
Hermans MP, Ahn SA, Rousseau MF. The atherogenic dyslipidemia ratio [log (TG)/HDL-C] is associated with residual vascular risk, beta-cell function loss and microangiopathy in type 2 diabetes females. Lipids Health Dis. 2012;11(1):132.
Karmoker JR, Joydhar P, Sarkar S, Rahman M. Comparative in vitro evaluation of various commercial brands of amlodipine besylate tablets marketed in Bangladesh. Asian J Pharm. 2016;6(1):1384-89.
Kumar M, Bhatia R, Rawal RK. Applications of various analytical techniques in quality control of pharmaceutical excipients. J Pharm Biomed Anal. 2018;157:122-36.
Nduka CU, Stranges S, Bloomfield GS, Kimani PK, Achinge G, Malu AO, Uthman OA. A plausible causal link between antiretroviral therapy and increased blood pressure in a sub-Saharan African setting: A propensity score-matched analysis. Int J Cardiol. 2016;220:400-7.
Osei-Yeboah F, Sun CC. Validation and applications of an expedited tablet friability method. Int J Pharm. 2015;484(1- 2):146-55.
Sakuda M, Yoshida N, Takaoka T, Sanada T, Rahman MS, Tanimoto T, Zin T, Kimura K, Tsuboi H. Substandard and falsified medicines in myanmar. Pharmacy. 2020;8(1):45.
Saraswati K, Sichanh C, Newton PN, Caillet C. Quality of medical products for diabetes management: a systematic review. BMJ Glob Health. 2019;4(5):e001636.
Shukla R, Singh R, Arfi S, Tiwari R, Tiwari G. Degradation and its forced effect: A trenchant tool for stability studies. Int J Pharm Biol. 2016;7(4):4987-95.
Szakonyi G, Zelkó R. The effect of water on the solid state characteristics of pharmaceutical excipients: Molecular mechanisms, measurement techniques, and quality aspects of final dosage form. Int J Pharm Investig. 2012;2(1):18-25.
Uddin MS, Al Mamun A, Hossain MS, Asaduzzaman M, Sarwar MS, Rashid M, Herrera-Calderon O. In vitro quality evaluation of leading brands of ciprofloxacin tablets available in Bangladesh. BMC Res Notes. 2017;10(1):185.
Verma N, Chattopadhyay P. Preparation of mucoadhesive patches for buccal administration of metoprolol succinate: in vitro and in vivo drug release and bioadhesion. Trop J Pharm Res. 2012;11(1):9-17.
Walston S, Al-Harbi Y, Al-Omar B. The changing face of healthcare in Saudi Arabia. Ann Saudi Med. 2008;28(4):243-50.
World Health Organization. Substandard and falsified medical products. 2018. Available at: Available at: https://www.who.int/news-room/fact-sheets/detail/substandard-and-falsified-medical-products (accessed May 2019).
» https://www.who.int/news-room/fact-sheets/detail/substandard-and-falsified-medical-products
Zhang L, Zalewski A, Liu Y, Mazurek T, Cowan S, Martin JL, Hofmann SM, Vlassara H, Shi Y. Diabetes-induced oxidative stress and low-grade inflammation in porcine coronary arteries. Circulation. 2003;108(4):472-8.
Zhou D. Understanding physicochemical properties for pharmaceutical product development and manufacturing II: physical and chemical stability and excipient compatibility. J Valid Technol. 2009;15(3):36-47.
Zilker M, Sörgel F, Holzgrabe U. A systematic review of the stability of finished pharmaceutical products and drug substances beyond their labeled expiry dates. J Pharm Biomed. 2019;166:222-35.
Downloads
Publicado
Edição
Seção
Licença
Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
All content of the journal, except where identified, is licensed under a Creative Commons attribution-type BY.
The on line journal has open and free access.
